| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 82 |
| 1 | METHOTREXATE | 68 |
| 2 | ADALIMUMAB | 56 |
| 3 | OXALIPLATIN | 45 |
| 4 | FLUOROURACIL | 43 |
| 5 | FLUOROURACIL CREAM, 0.5% | 43 |
| 6 | LEFLUNOMIDE | 39 |
| 7 | ETANERCEPT | 35 |
| 8 | METFORMIN | 32 |
| 9 | METFORMIN ER 500 MG | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLOXURIDINE | 12 | 0.0694 |
| 1 | SILTUXIMAB | 7 | 0.0108 |
| 2 | DIFLUPREDNATE OPHTHALMIC | 4 | 0.0045 |
| 3 | CLINDAMYCIN AND BENZOYL PEROXIDE | 1 | 0.0037 |
| 4 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 5 | ESTRADIOL VALERATE AND ESTRADIOL VALERATE/DIENOGEST | 1 | 0.0031 |
| 6 | POTASSIUM BICARBONATE | 2 | 0.0028 |
| 7 | METEX | 1 | 0.0026 |
| 8 | METRELEPTIN | 3 | 0.0024 |
| 9 | HYDROCORTISONE BUTYRATE | 4 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 82 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 80 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 68 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 53 |
| 4 | Platinum-based Drug [EPC] | 49 |
| 5 | Antirheumatic Agent [EPC] | 39 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 37 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 8 | Benzodiazepine [EPC] | 31 |
| 9 | Proton Pump Inhibitor [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 7 | 0.0108 |
| 1 | Leptin Analog [EPC] | 3 | 0.0024 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 7 | 0.0009 |
| 3 | Asparagine-specific Enzyme [EPC] | 11 | 0.0008 |
| 4 | Stimulant Laxative [EPC] | 7 | 0.0005 |
| 5 | Antirheumatic Agent [EPC] | 39 | 0.0004 |
| 6 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 80 | 0.0003 |
| 8 | Bile Acid [EPC] | 6 | 0.0003 |
| 9 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 13 | 0.0002 |